8/18/2026
Puerto Rico advances psychedelic therapy research
Governor's order initiates ibogaine, MDMA, and psilocybin study
Topic archive
psilocybin
4 stories
8/8/2026
Psyence BioMed focuses on psilocybin and ibogaine supply
The biotech firm aims for vertical integration in psychedelic therapeutics.
8/7/2026
Psyence Biomedical unveils strategic plans in new investor presentation
Psyence Biomedical outlines its focus on psychedelic therapeutics for mental health in a recent investor update.
7/31/2026
Ibogaine research gains momentum in Mississippi
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.